US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 43.280
  • -0.760-1.73%
Close Sep 6 16:00 ET
  • 43.280
  • 0.0000.00%
Post 16:20 ET
2.46BMarket Cap-6658P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Agios Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
9.31M
8.62M
-692.30K
Miss Est.
+38.67%
+28.35%
-7.44%
EPS
-1.60
-1.69
-0.09
Miss Est.
-6.10%
-11.92%
-5.49%
Analyst Rating
Strong Buy

Sep 7, 2024

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 11.467M--
--2024/Q3-- / 10.128M--
Aug 1, 20242024/Q28.615M / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--
Feb 15, 20242023/Q47.103M / 7.924M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 11.467M--
--2024/Q3-- / 10.128M--
Aug 1, 20242024/Q28.615M / 9.307M--
May 2, 20242024/Q18.189M / 8.372M--
Feb 15, 20242023/Q47.103M / 7.924M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

  • Agios Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 21:51

  • Agios Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 2 21:23

  • Agios Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 15 23:37

  • Agios Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 21:20

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 7, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg